• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结核分枝杆菌 L,D-转肽酶 2 及其天然单体底物的生化和晶体学研究。

Biochemical and crystallographic studies of L,D-transpeptidase 2 from Mycobacterium tuberculosis with its natural monomer substrate.

机构信息

Chemistry Research Laboratory, Department of Chemistry and the Ineos Oxford Institute of Antimicrobial Research, University of Oxford, Oxford, UK.

Enzymology and Applied Biocatalysis Research Center, Faculty of Chemistry and Chemical Engineering, Babes-Bolyai University, Cluj-Napoca, Romania.

出版信息

Commun Biol. 2024 Sep 18;7(1):1173. doi: 10.1038/s42003-024-06785-3.

DOI:10.1038/s42003-024-06785-3
PMID:39294212
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11410929/
Abstract

The essential L,D-transpeptidase of Mycobacterium tuberculosis (Ldt) catalyses the formation of 3 3 cross-links in cell wall peptidoglycan and is a target for development of antituberculosis therapeutics. Efforts to inhibit Ldt have been hampered by lack of knowledge of how it binds its substrate. To address this gap, we optimised the isolation of natural disaccharide tetrapeptide monomers from the Corynebacterium jeikeium bacterial cell wall through overproduction of the peptidoglycan sacculus. The tetrapeptides were used in binding / turnover assays and biophysical studies on Ldt We determined a crystal structure of wild-type Ldt reacted with its natural substrate, the tetrapeptide monomer of the peptidoglycan layer. This structure shows formation of a thioester linking the catalytic cysteine and the donor substrate, reflecting an intermediate in the transpeptidase reaction; it informs on the mode of entrance of the donor substrate into the Ldt active site. The results will be useful in design of Ldt inhibitors, including those based on substrate binding interactions, a strategy successfully employed for other nucleophilic cysteine enzymes.

摘要

结核分枝杆菌(Ldt)的必需 L,D-转肽酶催化细胞壁肽聚糖中 3 个 3 交叉连接的形成,是开发抗结核治疗药物的靶点。由于缺乏其结合底物的知识,抑制 Ldt 的努力受到了阻碍。为了解决这一差距,我们通过过度生产肽聚糖囊来优化从棒状杆菌属细胞壁中分离天然二糖四肽单体。这些四肽肽被用于结合/周转测定和 Ldt 的生物物理研究。我们确定了与天然底物反应的野生型 Ldt 的晶体结构,即肽聚糖层的四肽单体。该结构显示了催化半胱氨酸和供体底物之间形成硫酯键,反映了转肽酶反应的中间产物;它说明了供体底物进入 Ldt 活性位点的方式。这些结果将有助于设计 Ldt 抑制剂,包括基于底物结合相互作用的抑制剂,这是一种成功应用于其他亲核半胱氨酸酶的策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac5f/11410929/52ba94e5af3e/42003_2024_6785_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac5f/11410929/53b2cb514e6c/42003_2024_6785_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac5f/11410929/fd4e54da0510/42003_2024_6785_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac5f/11410929/e36df9fea1f5/42003_2024_6785_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac5f/11410929/52ba94e5af3e/42003_2024_6785_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac5f/11410929/53b2cb514e6c/42003_2024_6785_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac5f/11410929/fd4e54da0510/42003_2024_6785_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac5f/11410929/e36df9fea1f5/42003_2024_6785_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac5f/11410929/52ba94e5af3e/42003_2024_6785_Fig4_HTML.jpg

相似文献

1
Biochemical and crystallographic studies of L,D-transpeptidase 2 from Mycobacterium tuberculosis with its natural monomer substrate.结核分枝杆菌 L,D-转肽酶 2 及其天然单体底物的生化和晶体学研究。
Commun Biol. 2024 Sep 18;7(1):1173. doi: 10.1038/s42003-024-06785-3.
2
Xpert MTB/XDR for detection of pulmonary tuberculosis and resistance to isoniazid, fluoroquinolones, ethionamide, and amikacin.Xpert MTB/XDR 检测系统用于检测肺结核病及异烟肼、氟喹诺酮类、乙胺丁醇和阿米卡星耐药性。
Cochrane Database Syst Rev. 2022 May 18;5(5):CD014841. doi: 10.1002/14651858.CD014841.pub2.
3
Binding and processing of β-lactam antibiotics by the transpeptidase Ldt from Mycobacterium tuberculosis.结核分枝杆菌转肽酶Ldt对β-内酰胺类抗生素的结合与加工
FEBS J. 2017 Mar;284(5):725-741. doi: 10.1111/febs.14010. Epub 2017 Feb 8.
4
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
5
Rapid molecular tests for tuberculosis and tuberculosis drug resistance: a qualitative evidence synthesis of recipient and provider views.快速分子检测结核分枝杆菌和结核分枝杆菌耐药性:受检者和提供者观点的定性证据综合评价。
Cochrane Database Syst Rev. 2022 Apr 26;4(4):CD014877. doi: 10.1002/14651858.CD014877.pub2.
6
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
7
Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children.Xpert MTB/RIF Ultra assay 用于儿童结核病和利福平耐药检测。
Cochrane Database Syst Rev. 2022 Sep 6;9(9):CD013359. doi: 10.1002/14651858.CD013359.pub3.
8
Xpert MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance.用于肺外结核病和利福平耐药性的Xpert MTB/RIF检测
Cochrane Database Syst Rev. 2018 Aug 27;8(8):CD012768. doi: 10.1002/14651858.CD012768.pub2.
9
Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.染色体臂 1p 和 19q 缺失的检测在胶质瘤患者中的诊断准确性和成本效益。
Cochrane Database Syst Rev. 2022 Mar 2;3(3):CD013387. doi: 10.1002/14651858.CD013387.pub2.
10
Assembling of the Mycobacterium tuberculosis Cell Wall Core.结核分枝杆菌细胞壁核心的组装
J Biol Chem. 2016 Sep 2;291(36):18867-79. doi: 10.1074/jbc.M116.739227. Epub 2016 Jul 14.

本文引用的文献

1
High-throughput screen with the l,d-transpeptidase Ldt of reveals novel classes of covalently reacting inhibitors.对L,d-转肽酶Ldt进行高通量筛选,发现了新型共价反应抑制剂。
Chem Sci. 2023 May 30;14(26):7262-7278. doi: 10.1039/d2sc06858c. eCollection 2023 Jul 5.
2
X-ray crystallographic characterization of the SARS-CoV-2 main protease polyprotein cleavage sites essential for viral processing and maturation.SARS-CoV-2 主要蛋白酶多蛋白切割位点的 X 射线晶体学表征,这些切割位点对于病毒的加工和成熟至关重要。
Nat Commun. 2022 Sep 3;13(1):5196. doi: 10.1038/s41467-022-32854-4.
3
Allosteric cooperation in β-lactam binding to a non-classical transpeptidase.
变构协同作用在非经典转肽酶与β-内酰胺结合中的作用。
Elife. 2022 Apr 27;11:e73055. doi: 10.7554/eLife.73055.
4
An oral SARS-CoV-2 M inhibitor clinical candidate for the treatment of COVID-19.一种用于治疗 COVID-19 的口服 SARS-CoV-2 M 抑制剂临床候选药物。
Science. 2021 Dec 24;374(6575):1586-1593. doi: 10.1126/science.abl4784. Epub 2021 Nov 2.
5
A review of the latest research on M targeting SARS-COV inhibitors.关于靶向严重急性呼吸综合征冠状病毒(SARS-CoV)抑制剂的M的最新研究综述。
RSC Med Chem. 2021 Apr 14;12(7):1026-1036. doi: 10.1039/d1md00066g. eCollection 2021 Jul 21.
6
LD-transpeptidases: the great unknown among the peptidoglycan cross-linkers.溶菌酶转糖基酶:糖肽交联剂中的“无名英雄”。
FEBS J. 2022 Aug;289(16):4718-4730. doi: 10.1111/febs.16066. Epub 2021 Jun 22.
7
Global Tuberculosis Report 2020 - Reflections on the Global TB burden, treatment and prevention efforts.2020 年全球结核病报告——对全球结核病负担、治疗和预防工作的反思。
Int J Infect Dis. 2021 Dec;113 Suppl 1(Suppl 1):S7-S12. doi: 10.1016/j.ijid.2021.02.107. Epub 2021 Mar 11.
8
Crystallographic structure of wild-type SARS-CoV-2 main protease acyl-enzyme intermediate with physiological C-terminal autoprocessing site.野生型 SARS-CoV-2 主蛋白酶酰基酶中间产物与生理 C 末端自加工位点的晶体结构。
Nat Commun. 2020 Nov 18;11(1):5877. doi: 10.1038/s41467-020-19662-4.
9
β-lactam antibiotics: An overview from a medicinal chemistry perspective.β-内酰胺类抗生素:从药物化学角度综述。
Eur J Med Chem. 2020 Dec 15;208:112829. doi: 10.1016/j.ejmech.2020.112829. Epub 2020 Sep 16.
10
Substrate and Stereochemical Control of Peptidoglycan Cross-Linking by Transpeptidation by PBP1B.通过 PBP1B 的转肽作用对肽聚糖交联的底物和立体化学控制。
J Am Chem Soc. 2020 Mar 18;142(11):5034-5048. doi: 10.1021/jacs.9b08822. Epub 2020 Mar 2.